Benfotiamine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A11DA03
CAS registry number (Chemical Abstracts Service)
0022457-89-2
Chemical Formula
C19-H23-N4-O6-P-S
Molecular Weight
466
Therapeutic Category
Vitamin B₁
Chemical Name
Benzenecarbothioic acid, S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propenyl] ester
Foreign Names
- Benfotiaminum (Latin)
- Benfotiamin (German)
- Benfotiamine (French)
- Benfotiamina (Spanish)
Generic Names
- Benfotiamine (OS: DCF, JAN)
- Benzoylthiaminemonophosphate (IS)
- CB 8088 (IS)
Brand Names
- Benfogamma
Worwag, Slovakia; Wörwag Pharma, Bulgaria; Wörwag Pharma, Czech Republic; Wörwag Pharma, Estonia; Wörwag Pharma, Hungary; Wörwag Pharma, Lithuania; Wörwag Pharma, Latvia; Wörwag Pharma, Poland; Wörwag Pharma, Romania; Wörwag Pharma, Russian Federation - Biotamin
Daiichi Sankyo, Japan - Biotowa
Towa Yakuhin, Japan - milgamma (Benfotiamine and Cyanocobalamin)
Worwag, Slovakia; Wörwag Pharma, Bulgaria; Wörwag Pharma, Czech Republic; Wörwag Pharma, Latvia; Wörwag Pharma, Romania - milgamma (Benfotiamine and Pyridoxine)
Mauermann, Serbia; Mauermann-Arzneimittel, Georgia; Solupharm, Georgia; Worwag Pharma, Hong Kong; Wörwag Pharma, Bulgaria; Wörwag Pharma, Germany; Wörwag Pharma, Estonia; Wörwag Pharma, Lithuania; Wörwag Pharma, Latvia; Wörwag Pharma, Poland - Milgamma Composition (Benfotiamine and Pyridoxine)
Wörwag Pharma, Russian Federation - milgamma mono
Wörwag Pharma, Germany - milgamma protekt
Wörwag Pharma, Germany - Vitafos (Benfotiamine and Thiamine)
Swiss Pharm, Taiwan
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
